Guillain‐Barré syndrome following COVID‐19 vaccination: An updated systematic review of cases

KEY CLINICAL MESSAGE: Guillain‐Barré syndrome (GBS) is a rare but possible complication that may occur after COVID‐19 vaccination. In this systematic review, we found that GBS presented in patients with an average age of 58. The average time for symptoms to appear was 14.4 days. Health care provider...

Descripción completa

Detalles Bibliográficos
Autores principales: Shaheen, Nour, Ramadan, Abdelraouf, Nashwan, Abdulqadir J., Shaheen, Ahmed, Ahmad, Shahzaib, Motawea, Karam R., Mohamed, Salaheldin, Mohamed, Rahma Sameh, Swed, Sarya, Aiash, Hani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248205/
https://www.ncbi.nlm.nih.gov/pubmed/37305891
http://dx.doi.org/10.1002/ccr3.7456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248205/
https://www.ncbi.nlm.nih.gov/pubmed/37305891
http://dx.doi.org/10.1002/ccr3.7456

Ejemplares similares